hotspot gene TCR-T (K-Ras)

N/A

Report date: 2025/03/20 15:26:02

Base Information

Drug Namehotspot gene TCR-T (K-Ras)

Drug Alias Nameanti-K-Ras/p53 TCR T-cell therapy (China Immunotech)

ClassificationBiologics > Protein drugs > Recombinant proteinCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy

Mechanisms of ActionHuman leukocyte antigen modulatorsV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog modulatorsTumor protein p53 modulators

TargetsHuman leukocyte antigenGTPase KRasTumor protein p53

Therapy Area/IndicationsLung Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesChina Immunotech Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesChina Immunotech Co Ltd

Inactive CompaniesN/A

Active IndicationsLung Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A